Furthermore, the level of the brain injury biomarker S100β was significantly higher in the encephalopathy group (2.03 ± 0.18 μg/L vs. 2.15 ± 0.29 μg/L, P = .020) (Table 3). The gene discussed is S100B; the disease is Encephalopathy.